<DOC>
	<DOCNO>NCT03027856</DOCNO>
	<brief_summary>The purpose study investigate feasibility safety Magmaris BRS treatment coronary bifurcation lesion .</brief_summary>
	<brief_title>The BIFSORB Pilot Study II</brief_title>
	<detailed_description>Bioresorbable stent promise treatment coronary artery disease . The concept bifurcation treatment use BRS particular appeal strut cover side branch ostium may resorb time . The aim study investigate feasibility safety Magmaris BRS treatment coronary bifurcation lesion . Hypothesis : treatment coronary bifurcation lesion use Magmaris BRS safe feasible . Methods : The study proof-of-concept , prospective , single arm study inclusion 10 patient . Planned 1-month follow-up optical coherence tomography ( OCT ) follow-up clinical endpoint 5 year . Written informed consent require procedure perform . Eligible patient bifurcation lesion treat provisional technique mandatory jailing side branch provisional opening side branch ostium mini-kiss technique case severe pinch TIMI-flow le III . Proximal post-dilatation mandatory . No dilatation beyond expansion limit stent . At baseline , target lesion assess OCT , implantation Magmaris BRS . OCT assessment perform 1-month follow-up , patient readmitted possible target lesion failure . The operator blind OCT image pre-PCI image use size position stent , procedural OCT image use optimize stent implantation perform final OCT .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Stable angina pectoris Stabilized nonST elevation myocardial infarction Silent angina pectoris Age &gt; 18 year De novo coronary bifurcation lesion LAD/diagonal , CX/obtuse marginal RCAPDA/posterolateral branch All Medina class except Medina x.x.1 . Diameter side branch ≥ 2.5 mm Side branch diameter stenosis le 50 % Signed informed consent STelevation infarction within 48 hour Expected survival &lt; 1 year Severe heart failure ( NYHA≥III ) Screatinine &gt; 120 µmol/L GFR &lt; 0.45 mL/min per 1.73 m2 Allergy contrast medium , aspirin , clopidogrel , ticagrelor , ticlopidine sirolimus Unable cover main vessel lesion one stent Severe tortuosity Severe calcification</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Percutaneous intervention ( PCI )</keyword>
	<keyword>Optical coherence tomography ( OCT )</keyword>
	<keyword>Bifurcation lesion</keyword>
	<keyword>Bioresorbable stent ( BRS )</keyword>
</DOC>